Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China.
Department of Neurology and Radiology, Boston Medical Center, Boston, Massachusetts, USA.
Eur J Neurol. 2024 Dec;31(12):e16458. doi: 10.1111/ene.16458. Epub 2024 Sep 10.
The benefit of remote ischaemic conditioning (RIC) in acute moderate ischaemic stroke has been demonstrated by the Remote Ischaemic Conditioning for Acute Moderate Ischaemic Stroke (RICAMIS) study. This prespecified exploratory analysis aimed to determine whether there was a difference of RIC efficacy in anterior versus posterior circulation stroke based on RICAMIS data.
In this analysis, eligible patients presenting within 48 h of stroke onset were divided into two groups: anterior circulation stroke (ACS) and posterior circulation stroke (PCS) groups. The primary endpoint was an excellent functional outcome, defined as a modified Rankin Scale (mRS) score 0-1 at 90 days.
In all, 1013 patients were included in the final analysis, including 642 with ACS and 371 with PCS. Compared with the control group, RIC was significantly associated with an increased proportion of mRS scores 0-1 within 90 days in the PCS group (unadjusted odds ratio 1.6, 95% confidence interval 1.0-2.4, p = 0.04; adjusted odds ratio 2.0, 95% confidence interval 1.2-3.3, p = 0.005), but not in the ACS group (p = 0.29). Similar results were found regarding secondary outcomes including mRS score 0-2 at 90 days, mRS distribution at 90 days and change in National Institutes of Health Stroke Scale score at day 12 from baseline. However, there was no significant interaction effect between stroke location and intervention on the primary outcome (p = 0.21).
Amongst patients with acute PCS who are not candidates for reperfusion treatment, RIC may be associated with a higher probability of improved functional outcomes. These findings need to be validated in prospective trials.
远程缺血预处理(RIC)在急性中度缺血性卒中中的益处已被急性中度缺血性卒中的远程缺血预处理研究(RICAMIS)证实。本预先设定的探索性分析旨在根据 RICAMIS 数据确定 RIC 在前后循环卒中中的疗效是否存在差异。
在这项分析中,符合条件的发病 48 小时内的患者被分为两组:前循环卒中(ACS)和后循环卒中(PCS)组。主要终点是 90 天的改良 Rankin 量表(mRS)评分 0-1 的良好功能结局。
共有 1013 例患者纳入最终分析,其中 642 例为 ACS,371 例为 PCS。与对照组相比,RIC 与 PCS 组 90 天内 mRS 评分 0-1 的比例显著增加相关(未校正优势比 1.6,95%置信区间 1.0-2.4,p=0.04;校正优势比 2.0,95%置信区间 1.2-3.3,p=0.005),但在 ACS 组中则不然(p=0.29)。次要结局包括 90 天 mRS 评分 0-2、90 天 mRS 分布和基线至第 12 天 NIHSS 评分的变化,也得出了类似的结果。然而,在主要结局方面,卒中部位与干预之间没有显著的交互作用(p=0.21)。
对于不适合再灌注治疗的急性 PCS 患者,RIC 可能与更高的功能结局改善概率相关。这些发现需要在前瞻性试验中得到验证。